Drugs & Targets Imbruvica Granted 5th Approval, For First-Line CLL Patients March 04, 2016Vol.42 No.09
Drugs & Targets FDA Approves Gazyva Plus Bendamustine for Patients with Follicular Lymphoma February 29, 2016Vol.39 No.02
Drugs & Targets FDA grants Breakthrough Designation to PKC412 (midostaurin) February 26, 2016Vol.42 No.08
Drugs & Targets FDA approves Afinitor for GI or lung neuroendocrine tumors February 26, 2016Vol.42 No.08
Drugs & Targets FDA grants orphan designation to antifungal drug candidate CD101 IV February 12, 2016Vol.42 No.06
Drugs & Targets Mayo Clinic collaborates with Morphotek in triple-negative breast cancer study. February 05, 2016Vol.42 No.05
Drugs & Targets FDA tells Telesta they need another phase III MCNA trial February 05, 2016Vol.42 No.05
